
Clinical Trials - January 8, 2014
Patient recruitment completed in Phase I/II study of Umecrine Mood’s candidate drug
Umecrine Mood AB had announced that patient recruitment for the ongoing phase I/II study with UC1010 for the treatment of severe premenstrual symptoms (PMDD) has been completed. Umecrine Mood is part of the Karolinska Development portfolio. ”About half of the patients planned for the study have completed the treatment. The remaining participants are currently in […]